Impact Analysis of Covid-19
The complete version of the REPORT will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Cytotoxic drugs inhibit or prevent the function of cells. Cytotoxic drugs are primarily used to treat cancer, frequently as part of a chemotherapy regime. Recently, their uses have expanded to treat certain skin conditions (e.g., psoriasis), rheumatoid and juvenile rheumatoid arthritis, and steroid-resistant muscle conditions. The most common forms of cytotoxic drugs are known as antineoplastic. The terms ‘antineoplastic' and ‘cytotoxic' are often used interchangeably.
Scope of the Report:
This report focuses on the Cytotoxic Drug in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.
Market Segment by Manufacturers, this report covers
Roche
Eli Lilly
Celgene
Sanofi
eisai
Sumitomo Dainippon Pharma
Merck
Seattle Genetics
Takeda
Haosoh Pharma
Novartis
AstraZeneca
Jazz Pharma
Spectrum Pharma
Market Segment by Countries, covering
United States
Canada
Mexico
Market Segment by Type, covers
Injection
Solid Oral Dose Forms
Others
Market Segment by Applications, can be divided into
Breast Cancer
Blood Cancer
Prostate Cancer
Respiratory/Lung Cancer
Other
There are 15 Chapters to deeply display the North America Cytotoxic Drug market.
Chapter 1, to describe Cytotoxic Drug Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Cytotoxic Drug, with profile, main business, news, sales, price, revenue and market share in 2018 and 2019;
Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2018 and 2019;
Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Cytotoxic Drug, for each country, from 2014 to 2019;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2014 to 2019;
Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;
Chapter 10, Cytotoxic Drug market forecast, by countries, type and application, with sales, price and revenue, from 2019 to 2025;
Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.
Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);
Chapter 13, to describe sales channel, distributors, traders, dealers etc.
Chapter 14 and 15, to describe Cytotoxic Drug Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents
1 Market Overview
1.1 Cytotoxic Drug Introduction
1.2 Market Analysis by Type
1.2.1 Injection
1.2.2 Solid Oral Dose Forms
1.2.3 Others
1.3 Market Analysis by Applications
1.3.1 Breast Cancer
1.3.2 Blood Cancer
1.3.3 Prostate Cancer
1.3.4 Respiratory/Lung Cancer
1.3.5 Other
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2014-2024)
1.4.2 Mexico Status and Prospect (2014-2024)
1.4.3 Canada Status and Prospect (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Profile
2.1.2 Cytotoxic Drug Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Roche Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.1.4 Business Overview
2.1.5 Roche News
2.2 Eli Lilly
2.2.1 Profile
2.2.2 Cytotoxic Drug Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Eli Lilly Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2.4 Business Overview
2.2.5 Eli Lilly News
2.3 Celgene
2.3.1 Profile
2.3.2 Cytotoxic Drug Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Celgene Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3.4 Business Overview
2.3.5 Celgene News
2.4 Sanofi
2.4.1 Profile
2.4.2 Cytotoxic Drug Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Sanofi Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4.4 Business Overview
2.4.5 Sanofi News
2.5 eisai
2.5.1 Profile
2.5.2 Cytotoxic Drug Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 eisai Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5.4 Business Overview
2.5.5 eisai News
2.6 Sumitomo Dainippon Pharma
2.6.1 Profile
2.6.2 Cytotoxic Drug Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Sumitomo Dainippon Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6.4 Business Overview
2.6.5 Sumitomo Dainippon Pharma News
2.7 Merck
2.7.1 Profile
2.7.2 Cytotoxic Drug Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Merck Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7.4 Business Overview
2.7.5 Merck News
2.8 Seattle Genetics
2.8.1 Profile
2.8.2 Cytotoxic Drug Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Seattle Genetics Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8.4 Business Overview
2.8.5 Seattle Genetics News
2.9 Takeda
2.9.1 Profile
2.9.2 Cytotoxic Drug Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Takeda Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9.4 Business Overview
2.9.5 Takeda News
2.10 Haosoh Pharma
2.10.1 Profile
2.10.2 Cytotoxic Drug Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Haosoh Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10.4 Business Overview
2.10.5 Haosoh Pharma News
2.11 Novartis
2.11.1 Profile
2.11.2 Cytotoxic Drug Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Novartis Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11.4 Business Overview
2.11.5 Novartis News
2.12 AstraZeneca
2.12.1 Profile
2.12.2 Cytotoxic Drug Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 AstraZeneca Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12.4 Business Overview
2.12.5 AstraZeneca News
2.13 Jazz Pharma
2.13.1 Profile
2.13.2 Cytotoxic Drug Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Jazz Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13.4 Business Overview
2.13.5 Jazz Pharma News
2.14 Spectrum Pharma
2.14.1 Profile
2.14.2 Cytotoxic Drug Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Spectrum Pharma Cytotoxic Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14.4 Business Overview
2.14.5 Spectrum Pharma News
3 North America Cytotoxic Drug Market Competition, by Manufacturer
3.1 North America Cytotoxic Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 North America Cytotoxic Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 North America Cytotoxic Drug Price by Manufacturers (2018-2019)
3.4 Market Concentration Rate
3.4.1 Top 3 Cytotoxic Drug Manufacturer Market Share
3.4.2 Top 5 Cytotoxic Drug Manufacturer Market Share
3.5 Market Competition Trend
4 North America Cytotoxic Drug Market Analysis by Countries
4.1 North America Cytotoxic Drug Sales Market Share by Countries
4.2 North America Cytotoxic Drug Sales by Countries (2014-2019)
4.3 North America Cytotoxic Drug Revenue (Value) by Countries (2014-2019)
5 North America Market Segmentation Cytotoxic Drug by Type
5.1 North America Cytotoxic Drug Sales, Revenue and Market Share by Type (2014-2019)
5.1.1 North America Cytotoxic Drug Sales and Market Share by Type (2014-2019)
5.1.2 North America Cytotoxic Drug Revenue and Market Share by Type (2014-2019)
5.2 Injection Sales Growth and Price
5.2.1 North America Injection Sales Growth (2014-2019)
5.2.2 North America Injection Price (2014-2019)
5.3 Solid Oral Dose Forms Sales Growth and Price
5.3.1 North America Solid Oral Dose Forms Sales Growth (2014-2019)
5.3.2 North America Solid Oral Dose Forms Price (2014-2019)
5.4 Others Sales Growth and Price
5.4.1 North America Others Sales Growth (2014-2019)
5.4.2 North America Others Price (2014-2019)
6 North America Market Segmentation Cytotoxic Drug by Application
6.1 North America Cytotoxic Drug Sales Market Share by Application (2014-2019)
6.2 Breast Cancer Sales Growth (2014-2019)
6.3 Blood Cancer Sales Growth (2014-2019)
6.4 Prostate Cancer Sales Growth (2014-2019)
6.5 Respiratory/Lung Cancer Sales Growth (2014-2019)
6.6 Other Sales Growth (2014-2019)
7 United States Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Cytotoxic Drug Revenue, Sales and Growth Rate (2014-2019)
7.2 United States Cytotoxic Drug Sales and Market Share by Type
7.3 United States Cytotoxic Drug Sales by Application (2014-2019)
7.4 United States Cytotoxic Drug Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Cytotoxic Drug Sales and Market Share by Manufacturer
7.4.2 United States Cytotoxic Drug Revenue and Market Share by Manufacturer
7.5 United States Cytotoxic Drug Export and Import (2014-2019)
8 Canada Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Cytotoxic Drug Revenue, Sales and Growth Rate (2014-2019)
8.2 Canada Cytotoxic Drug Sales and Market Share by Type
8.3 Canada Cytotoxic Drug Sales by Application (2014-2019)
8.4 Canada Cytotoxic Drug Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Cytotoxic Drug Sales and Market Share by Manufacturer
8.4.2 Canada Cytotoxic Drug Revenue and Market Share by Manufacturer
8.5 Canada Cytotoxic Drug Export and Import (2014-2019)
9 Mexico Cytotoxic Drug Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Cytotoxic Drug Revenue, Sales and Growth Rate (2014-2019)
9.2 Mexico Cytotoxic Drug Sales and Market Share by Type
9.3 Mexico Cytotoxic Drug Sales by Application (2014-2019)
9.4 Mexico Cytotoxic Drug Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Cytotoxic Drug Sales and Market Share by Manufacturer
9.4.2 Mexico Cytotoxic Drug Revenue and Market Share by Manufacturer
9.5 Mexico Cytotoxic Drug Export and Import (2014-2019)
10 Cytotoxic Drug Market Forecast (2019-2024)
10.1 North America Cytotoxic Drug Sales, Revenue and Growth Rate (2019-2024)
10.2 Cytotoxic Drug Market Forecast by Countries (2019-2024)
10.2.1 United States Cytotoxic Drug Forecast (2019-2024)
10.2.2 Canada Cytotoxic Drug Forecast (2019-2024)
10.2.3 Mexico Cytotoxic Drug Forecast (2019-2024)
10.3 Cytotoxic Drug Market Forecast by Type (2019-2024)
10.4 Cytotoxic Drug Market Forecast by Application (2019-2024)
11 Cytotoxic Drug Manufacturing Cost Analysis
11.1 Cytotoxic Drug Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Cytotoxic Drug
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Cytotoxic Drug Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Cytotoxic Drug Major Manufacturers in 2018
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source
